1952
DOI: 10.1111/j.1476-5381.1952.tb00719.x
|View full text |Cite
|
Sign up to set email alerts
|

The Ganglion Blocking Properties of Homologous Compounds in the Methonium Series

Abstract: Speculation on the relationship of pharmacological activity to chemical structure is a fascinating occupation, though a complex one. An apparently small alteration in molecular configuration may profoundly change the actions of a compound; a well-known example of this is the change in neuromuscular blocking activity brought about by the replacement of methyl by ethyl groups in quaternary ammonium ions (Ing, 1936). In a preceding paper (Wien and Mason, 1951) we found that the ability of hexamethonium to paralys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
10
1

Year Published

1954
1954
2013
2013

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 9 publications
0
10
1
Order By: Relevance
“…Atropine is also known to block the effect (not the receptors) of nicotine, as the end effect of nicotine in gut preparations is eventually due to release of ACh from myenteric plexus, which in turn activates muscarinic receptors at the end organ (25). To see whether the spasmogenic effect of the plant extract was mediated beyond the level of autonomic ganglia, the tissues were pretreated with hexamethonium (0.3 mM), a ganglion blocker (26). This treatment blocked the effect of nicotine (10 µM), but the effect of the ginger extract remained unaltered (data not shown), suggesting that the plant extract is devoid of any nicotinic effect and the spasmogenic effect observed is mediated through direct stimulation of muscarinic receptors.…”
Section: Discussionmentioning
confidence: 98%
“…Atropine is also known to block the effect (not the receptors) of nicotine, as the end effect of nicotine in gut preparations is eventually due to release of ACh from myenteric plexus, which in turn activates muscarinic receptors at the end organ (25). To see whether the spasmogenic effect of the plant extract was mediated beyond the level of autonomic ganglia, the tissues were pretreated with hexamethonium (0.3 mM), a ganglion blocker (26). This treatment blocked the effect of nicotine (10 µM), but the effect of the ginger extract remained unaltered (data not shown), suggesting that the plant extract is devoid of any nicotinic effect and the spasmogenic effect observed is mediated through direct stimulation of muscarinic receptors.…”
Section: Discussionmentioning
confidence: 98%
“…Co-administration of atropine and SB203186 failed to completely block the stimulatory effect of the plant extract and its aqueous fraction, suggestive of some additional mechanism(s) in the spasmodic effect of Ispaghula. To further characterize the stimulatory effect of Po.Cr, the tissue was pretreated with pyrilamine, an H 1 receptor blocker [58], and hexamethonium, a ganglion blocker [59], but the fact that neither of these affected the stimulatory effect of Po.Cr indicates a third component of the stimulatory effect of Ispaghula involving neither histaminic nor nicotinic receptor activation; this remains to be elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…However, the efficacy of gut stimulant effect was high in guinea-pig ileum than that found in rabbit jejunum. To further study the nature of the unknown additional spasmodic components, other than cholinergic, the stimulant effect was restudied in the presence of pyrilamine, a histaminic type-1 (H 1 ) receptor blocker [17], hexamethonium, a ganglion blocker [18] or SB203186, a serotonergic (5-HT) receptor antagonist [19]. But VBME showed complete resistance to these antagonists, clearly suggesting some additional mechanism(s), independent of histamine, nicotine or 5-Hydroxytryptamine (5-HT, serotonin) receptors activation.…”
Section: Discussionmentioning
confidence: 99%